Prognostic significance of elevated serum tumor markers (STM) after the first cycle of chemotherapy in patients with intermediate and poor risk non seminomatous testicular germ cell tumors (NSGCT)

被引：0
|
作者：
Batra, A. [1 ]
Nayak, B. [2 ]
Singh, P. [2 ]
Sahoo, R. K. [2 ]
Kunhiparambath, H. [3 ]
Kaushal, S. [4 ]
Seth, A. [2 ]
Varshney, A. N. [1 ]
Raj, A. [1 ]
机构：
[1] All India Inst Med Sci, Dept Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Urol, New Delhi, India
[3] All India Inst Med Sci, Dept Radiotherapy & Oncol, New Delhi, India
[4] All India Inst Med Sci, Pathol, New Delhi, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515P
引用
收藏
页码：S778 / S778
页数：1
相关论文
共 50 条
  • [21] FLT-PET for monitoring chemotherapy in patients with metastatic non-seminomatous testicular germ cell tumors
    Been, LB
    Cobben, DC
    Hoekstra, HJ
    Jager, PL
    Gietema, JA
    Elsinga, PH
    Suurmeijer, AJ
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 80 - 80
  • [22] Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients.
    Leao, Ricardo Romao Nazario
    Van Agthoven, Ton
    Figueiredo, Arnaldo
    Fadaak, Kamel
    Castelo-Branco, Pedro
    Jewett, Michael A. S.
    Sweet, Joan
    Ahmad, Ardalan
    Anson-Cartwright, Lynn
    Bedard, Philippe L.
    Chung, Peter W. M.
    Hansen, Aaron Richard
    Warde, Padraig Richard
    O'Malley, Martin
    Looijenga, Leendert
    Hamilton, Robert James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Paclitaxel, ifosfamide and cisplatin (TIP) in patients (pts) with poor prognosis nonseminomatous germ cell tumor (NSGCT) with unfavourable serum tumor markers (STM) decline: A phase II study
    Israelyan, E. R.
    Tryakin, A.
    Rumyantsev, A.
    Fedyanin, M.
    Tyulyandina, A.
    Klimov, A.
    Matveev, V.
    Volkova, M. I.
    Paychadze, A.
    Bychkov, Y.
    Yunaev, G.
    Tsareva, A.
    Tikhomirova, T.
    Zorinova, A.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S543 - S543
  • [24] Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers
    De Latour, Bertrand
    Fadel, Elie
    Mercier, Olaf
    Mussot, Sacha
    Fabre, Dominique
    Fizazi, Karim
    Dartevelle, Philippe
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 42 (01) : 66 - 71
  • [25] Resection of post-chemotherapy residual masses (RMs) in patients with advanced non-seminomatous germ cell tumors (NSGCT): prediction of outcomes
    Mediano Rambla, M.
    Thiery-Vuillemin, A.
    Alonso, M.
    Ocon, E.
    Conde, M.
    Sancho, P.
    Osman, I.
    Robles, C.
    Medina, R.
    Duran, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S650 - S650
  • [26] Prognostic significance of early predicted time to normalization (TTN) of tumor markers in advanced nonseminomatous germ cell tumors (NSGCT): validation study
    Tryakin, A.
    Tjulandin, S.
    Titov, D.
    Zakharova, T.
    Figurin, K.
    Mitin, A.
    Fainstein, I.
    Garin, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 250 - 250
  • [27] Extremely high level of tumor markers do not worsen outcome of nonseminomatous germ cell tumors (NSGCT) patients with poor prognosis
    Tryakin, A
    Tjulandin, S
    Titov, D
    Zakharova, T
    Figurin, K
    Feinstein, I
    Garin, A
    ANNALS OF ONCOLOGY, 2005, 16 : 292 - 292
  • [28] Risk stratification of clinical stage I (CSI) non-seminomatous germ cell testicular tumors (NSGCT): A retrospective analysis of experience at Indiana University (IU).
    Tatineni, Sushma
    Durm, Greg Andrew
    Kunapareddy, Girish Chandra
    Ammakkanavar, Natraj Reddy
    Dropcho, Edward F.
    Althouse, Sandra
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Albany, Costantine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Serum alpha fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance
    de Wit, R
    Collette, L
    Sylvester, R
    de Mulder, PHM
    Sleijfer, DT
    Huinink, WWT
    Kaye, SB
    van Oosterom, AT
    Boven, E
    Stoter, G
    BRITISH JOURNAL OF CANCER, 1998, 78 (10) : 1350 - 1355
  • [30] Viable malignant cells after primary chemotherapy for disseminated non-seminomatous germ-cell tumors (NSGCT): An international validation study.
    Fizazi, K
    Dunant, A
    Oldenburg, J
    Chen, I
    Salvioni, R
    Hartmann, JT
    Daugaard, G
    Flechon, A
    Bouzy, J
    Fromont, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 383S - 383S
12345